移植云学院2019年下半年学术盘点

石炳毅; 武小桐; 李宁; 陈知水; 郭晖; 陈江华; 王仁定; 朱志军; 刘颖

doi:10.3969/j.issn.1674-7445.2020.02.022

移植云学院2019年下半年学术盘点

doi: 10.3969/j.issn.1674-7445.2020.02.022

100091 北京，中国人民解放军总医院第八医学中心全军器官移植研究所（石炳毅）；山西省第二人民医院移植中心（武小桐、李宁）；华中科技大学同济医学院附属同济医院器官移植研究所（陈知水、郭晖）；浙江大学医学院附属第一医院肾脏病中心（陈江华、王仁定）；首都医科大学附属北京友谊医院普外科（朱志军、刘颖）

基金项目:

国家自然科学基金 81570680

详细信息

通讯作者:
石炳毅，男，1951年生，教授，主任医师，研究方向为器官移植临床与基础免疫学，Email:shibingyi666@126.com

中图分类号: R617
计量
- 文章访问数: 105
- HTML全文浏览量: 58
- PDF下载量: 24
- 被引次数: 0
出版历程
- 收稿日期: 2019-12-19
- 网络出版日期: 2021-01-19
- 刊出日期: 2020-03-15

Transplant Cloud College academy inventory in the second half of 2019

Organ Transplantation Institute of the 8th Medical Center of Chinese PLA General Hospital, Beijing 100091, China

More Information

Corresponding author: Shi Bingyi, Email: shibingyi666@126.com

摘要

摘要: 中国研究型医院学会携手医邻网共同打造的“移植云学院”于2019年下半年继续成功地举办了本年度的最后4期。在下半年的授课中，各中心讲师分别以肾移植术后高尿酸血症（HUA）的管理、移植肾病理学、肾移植急性抗体介导的排斥反应（AMR）的诊治、肝移植术后肺部感染为主题，与参会人员从多角度对肾移植和肝移植进行深入探讨。
- 肾移植 /
- 肝移植 /
- 人类白细胞抗原 /
- 抗体介导的排斥反应 /
- 估算肾小球滤过率 /
- 糖尿病肾病 /
- 高尿酸血症 /
- 感染
Abstract: In the second half of 2019, the last four sessions of Transplant Cloud College jointly established by Chinese Research Hospital Association and Medical Neighbor Network were successfully held. During the courses in the second half of this year, the lecturers from each institution mainly focused upon four topics including management of hyperuricemia (HUA) after kidney transplantation, renal graft pathology, diagnosis and treatment of acute antibody-mediated rejection (AMR) after kidney transplantation and pulmonary infection after liver transplantation. All participants delivered discussions and exchanges in kidney and liver transplantation from multiple perspectives.
- Kidney transplantation /
- Liver transplantation /
- Human leukocyte antigen /
- Antibody-mediated rejection /
- Estimated glomerular filtration rate /
- Diabetic kidney disease /
- Hyperuricemia /
- Infection

HTML全文

图 1 移植云学院专家阵容

Figure 1. expert team of transplantation cloud college

下载: 全尺寸图片幻灯片

参考文献(13)

[1]	BELLOMO G. Asymptomatic hyperuricemia following renal transplantation[J]. World J Nephrol, 2015, 4(3):324-329. DOI: 10.5527/wjn.v4.i3.324.
[2]	KALANTAR E, KHALILI N, HOSSIENI MS, et al. Hyperuricemia after renal transplantation[J]. Transplant Proc, 2011, 43(2):584-585. DOI:10.1016/j.transproceed. 2011.01.062.
[3]	中华医学会风湿病学分会.2016中国痛风诊疗指南[J].中华内科杂志, 2016, 55(11):892-899. DOI: 10.3760/cma.j.issn.0578-1426.2016.11.019. Chinese Rheumatology Association. 2016 China gout clinical practice guideline[J].Chin J Intern Med, 2016, 55(11):892-899. DOI: 10.3760/cma.j.issn.0578-1426.2016.11.019.
[4]	中华医学会器官移植学分会.器官移植病理学临床技术操作规范(2019版)——总论与肾移植[J].器官移植, 2019, 10(2):128-141.DOI:10.3969/j.issn.1674-7445. 2019.02.004. Branch of Organ Transplantation of Chinese Medical Association. Clinical technical operation specification for pathology of organ transplantation (2019 edition): general introduction and kidney transplantation[J]. Organ Transplant, 2019, 10(2):128-141.DOI:10.3969/j.issn. 1674-7445.2019.02.004.
[5]	TERVAERT TW, MOOYAART AL, AMANN K, et al. Pathologic classification of diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21(4):556-563. DOI: 10.1681/ASN.2010010010.
[6]	MOHAN S, PALANISAMY A, TSAPEPAS D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes[J]. J Am Soc Nephrol, 2012, 23(12):2061-2071. DOI: 10.1681/ASN.2012070664.
[7]	WAN SS, YING TD, WYBURN K, et al. The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and Meta-analysis[J]. Transplantation, 2018, 102(4):557-568. DOI: 10.1097/TP.0000000000002049.
[8]	VELIDEDEOGLU E, CAVAILLÉ-COLL MW, BALA S, et al. Summary of 2017 FDA public workshop: antibody-mediated rejection in kidney transplantation[J]. Transplantation, 2018, 102(6):e257-e264. DOI: 10.1097/TP.0000000000002141.
[9]	ECHENIQUE IA, ISON MG. Update on donor-derived infections in liver transplantation[J]. Liver Transpl, 2013, 19(6):575-585. DOI: 10.1002/lt.23640.
[10]	ERRICO G, GAGLIOTTI C, MONACO M, et al. Colonization and infection due to carbapenemase-producing enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy[J]. Clin Microbiol Infect, 2019, 25(2):203-209. DOI: 10.1016/j.cmi.2018.05.003.
[11]	中华医学会器官移植学分会.器官移植术后耐药菌感染诊疗技术规范(2019版)[J].器官移植, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445.2019.04.002. Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of drug-resistant bacterial infection after organ transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445. 2019.04.002.
[12]	中华医学会器官移植学分会.实体器官移植术后感染诊疗技术规范(2019版)——总论与细菌性肺炎[J].器官移植, 2019, 10(4): 343-351. DOI: 10.3969/j.issn. 1674-7445.2019.04.001. Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of infection after solid organ transplantation (2019 edition): general discussion and bacterial pneumonia[J]. Organ Transplant, 2019, 10(4): 343-351. DOI: 10.3969/j.issn.1674-7445.2019.04.001.
[13]	中华医学会器官移植学分会.器官移植供者来源性感染诊疗技术规范(2019版)[J].器官移植, 2019, 10(4): 369-375. DOI: 10.3969/j.issn.1674-7445.2019.04.005. Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of donor-derived infection in organ transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(4): 369-375. DOI: 10.3969/j.issn.1674-7445.2019.04.005.